alpha-aminopyridine has been researched along with Hormone-Dependent Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, S; Hirashima, T; Hozaka, Y; Kijima, Y; Nohata, N; Ohtsuka, T; Okada, R; Seki, N; Shinden, Y; Tanaka, T; Toda, H | 1 |
| Choi, HJ; Choi, JW; Jang, KS; Kang, JH; Kim, HY; Kim, S; Kong, G; Lee, JY; Oh, SH; Oh, YH; Park, JH; Shin, DH; Son, T; Won, HY; Woo, JK; Yi, K | 1 |
| Basse, C; Dieras, V; Jobard, A; Le Tourneau, C; Loirat, D; Ricci, F; Romano, E; Sablin, MP | 1 |
3 other study(ies) available for alpha-aminopyridine and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Estrogens; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; MicroRNAs; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nuclear Proteins; Oncogenes; Piperazines; Progesterone; Prognosis; Progression-Free Survival; Pyridines; RNA Interference; RNA, Neoplasm; RNA, Small Interfering; Treatment Outcome | 2021 |
MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Topics: Aminopyridines; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Endopeptidases; Estrogen Receptor alpha; Estrogens; Female; Humans; Kaplan-Meier Estimate; Mice; Morpholines; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Polycomb Repressive Complex 1; Progesterone; Proportional Hazards Models; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Receptor, ErbB-2; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Sp1 Transcription Factor; Sumoylation; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53 | 2015 |
[Cell cycle inhibitors in endocrine receptor positive breast cancer].
Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Cycle; Cell Cycle Checkpoints; Clinical Trials as Topic; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Humans; Neoplasms, Hormone-Dependent; Piperazines; Protein Kinase Inhibitors; Purines; Pyridines | 2017 |